Healthcare News and Research

Latest Healthcare News and Research

FDA approves Actavis ANDA for guaifenesin/pseudoephedrine tablets to relieve chest congestion

Actavis plc and its partner Perrigo Company plc announced today that Actavis has received U.S. Food and Drug Administration approval for its Abbreviated New Drug Application for guaifenesin/pseudoephedrine tablets and that Perrigo will begin shipments in time for the cough/cold season to its retail and wholesale customers in the U.S. The product will be packaged and marketed under store and proprietary brands and will be a high quality, value alternative to Mucinex® D tablets.

2 Jun 2015

Consumer Reports announces commitment to help wipe out 'superbugs'

Consumer Reports, the world's largest and most trusted nonprofit consumer organization, today announced its commitment to help wipe out antibiotic-resistant bacteria or "superbugs." Infections related to the use of antibiotics sicken about 2.25 million Americans each year and kill 37,000, according to the Centers for Disease Control and Prevention.

2 Jun 2015

NSCLC treatment market forecast to reach $7.9 billion by 2020

The Non-Small Cell Lung Cancer treatment market will be driven primarily by the introduction of numerous premium therapies, particularly in second-line and squamous cell treatment settings, which either replace or combine with generic chemotherapies.

2 Jun 2015

Green Cross Biotherapeutics starts construction on new biopharmaceutical facility in Montreal

This is with great pride that Green Cross Biotherapeutics Inc. kicked off construction today on its biopharmaceutical facility that will be located on the Montreal Technoparc's Saint-Laurent Campus. The CA$315 million project represents one of the largest green field investment projects in Canada in the biopharmaceutical industry, giving place to the construction of the first intravenous immunoglobulin (IVIG) and albumin manufacturing plant in Canada.

2 Jun 2015

New York State lawmakers lend critical helping hand to CARE Act

New York State lawmakers lent a critical helping hand today to millions of family caregivers and those for whom they care by giving final legislative passage to the CARE Act, top priority legislation for AARP that will help New Yorkers age safely at home.

2 Jun 2015

PruittHealth announces expansion in Atlanta, Georgia

PruittHealth announced today its official expansion in Atlanta, Georgia. PruittHealth – Virginia Park spans 3.6 acres in one of the most historic beautiful areas of Atlanta known as Virginia-Highland. The 40,302 square foot building will allow PruittHealth to offer high-quality post-acute care services to 128 beds and 18 specialty vent beds.

2 Jun 2015

NCCN to host policy summit on emerging issues in tissue allocation

Tissue allocation is a growing issue of concern for many researchers due, in part, to expanding research interests in precision medicine. The increased demand by pharmaceutical and biotech companies for patient tissue specimens collected for clinical care and trials presents clinical, ethical, and legal issues.

2 Jun 2015

Helsinn launches Helsinn Integrative Care division at ASCO Annual Meeting

Helsinn, the Swiss Group focused on building quality cancer care, announces today that its recently launched Helsinn Integrative Care division is meeting the cancer community at booth 6033 at the American Society of Clinical Oncology Annual Meeting, May 29-June 2, Chicago, Illinois.

2 Jun 2015

Decipher genomic analysis platform predicts tumor responsiveness to neoadjuvant chemotherapy in MIBC patients

GenomeDx Biosciences today announced that the robust Decipher genomic analysis platform, successfully classified various subtypes of bladder cancer based on the genomic expression of certain biomarkers, including one type associated with resistance to cisplatin-based chemotherapy. Importantly, this unique genomic signature has potential as a tool to predict tumor responsiveness to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancers (MIBC).

2 Jun 2015

Genesis Rehab Services forms groundbreaking partnership with Zhejiang Bang-Er Medical Group

Genesis Rehab Services, a division of Genesis HealthCare, one of the nation's largest providers of post-acute care, today announced a groundbreaking partnership with Zhejiang Bang-Er Medical Group, an orthopedic hospital system in China.

2 Jun 2015

Philips to highlight range of Magnetic Resonance solutions at 23rd ISMRM

Royal Philips today announced the range of its Magnetic Resonance (MR) solutions to be showcased at the International Society for Magnetic Resonance in Medicine's (ISMRM) 23rd Annual Meeting & Exhibition in Toronto, Canada.

2 Jun 2015

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Upsher-Smith Laboratories, Inc. announced that it has received U.S. Food and Drug Administration approval of a supplemental new drug application (sNDA) for Qudexy XR (topiramate) extended-release capsules for use as initial monotherapy in patients two years of age and older who are experiencing partial-onset seizures (POS) or primary generalized tonic-clonic seizures.

2 Jun 2015

Bankers Healthcare Group named one of Central New York's Best Places to Work

Bankers Healthcare Group, the leading provider of financial solutions for healthcare professionals, has been named one of Central New York's Best Places to Work for the third consecutive year after earning first place in 2013. This year, BHG placed third among organizations with 51 or more employees.

2 Jun 2015

More patients experience phantom eye symptoms every day, say University of Liverpool researchers

Researchers from the University of Liverpool have found that approximately half of patients who have an eye removed because of a form of eye cancer experience 'phantom eye syndrome.'

2 Jun 2015

Novartis CTL019 CAR T cell therapy demonstrates potential to treat B-cell lymphomas

Novartis is highlighting data from an ongoing Phase II clinical study of CTL019, an investigational chimeric antigen receptor (CAR) T cell therapy, that indicate its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma.

2 Jun 2015

Trabectedin may be better than dacarbazine for treatment of soft tissue sarcoma

Janssen Research & Development, LLC announced data from the Phase 3 multicenter study SAR3007, which demonstrated a significant improvement in progression-free survival with trabectedin (YONDELIS®) compared to dacarbazine in patients with advanced liposarcoma (LPS) or leiomyosarcoma (LMS) previously treated with an anthracycline and at least one additional chemotherapy regimen.

2 Jun 2015

EIB supports research and development of new wireless hearing devices by William Demant

The European Investment Bank (EIB) is supporting the development of new wireless hearing devices and research into more effective acoustic implants by global leader William Demant Holding A/S through a EUR 110 million loan.

2 Jun 2015

People who have more social support less likely to experience intimate-partner violence

People who had more social support, including trust and a sense of belonging, were less likely to experience emotional or verbal abuse while in a relationship, said a study published today in the American Journal of Community Psychology.

2 Jun 2015

Invitae introduces new patient pay program to make genetic testing more affordable, accessible

Invitae Corporation, a genetic information company, announced today the launch of its new patient pay price for its full menu of genetic tests at $475 per indication.

2 Jun 2015

Group Health Research Institute conducts first randomized trial to tackle vaccine hesitancy

Group Health Research Institute conducted the first randomized trial to test an intervention aimed at improving hesitancy about early childhood vaccines by working directly with doctors. Vax Northwest, a Washington state public-private partnership, developed the intervention.

2 Jun 2015

Healthcare News and Research

Latest Healthcare News and Research

FDA approves Actavis ANDA for guaifenesin/pseudoephedrine tablets to relieve chest congestion

Consumer Reports announces commitment to help wipe out 'superbugs'

NSCLC treatment market forecast to reach $7.9 billion by 2020

Green Cross Biotherapeutics starts construction on new biopharmaceutical facility in Montreal

New York State lawmakers lend critical helping hand to CARE Act

PruittHealth announces expansion in Atlanta, Georgia

NCCN to host policy summit on emerging issues in tissue allocation

Helsinn launches Helsinn Integrative Care division at ASCO Annual Meeting

Decipher genomic analysis platform predicts tumor responsiveness to neoadjuvant chemotherapy in MIBC patients

Genesis Rehab Services forms groundbreaking partnership with Zhejiang Bang-Er Medical Group

Philips to highlight range of Magnetic Resonance solutions at 23rd ISMRM

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Bankers Healthcare Group named one of Central New York's Best Places to Work

More patients experience phantom eye symptoms every day, say University of Liverpool researchers

Novartis CTL019 CAR T cell therapy demonstrates potential to treat B-cell lymphomas

Trabectedin may be better than dacarbazine for treatment of soft tissue sarcoma

EIB supports research and development of new wireless hearing devices by William Demant

People who have more social support less likely to experience intimate-partner violence

Invitae introduces new patient pay program to make genetic testing more affordable, accessible

Group Health Research Institute conducts first randomized trial to tackle vaccine hesitancy

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Newsletters you may be interested in